127 related articles for article (PubMed ID: 37945468)
1. Trends and Disparities in Cardiovascular Death in Non-Hodgkin Lymphoma.
Tan MC; Yeo YH; Ibrahim R; Tan MX; Lee JZ; Deshmukh AJ; Guha A
Am J Cardiol; 2024 Jan; 210():276-278. PubMed ID: 37945468
[No Abstract] [Full Text] [Related]
2. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
[TBL] [Abstract][Full Text] [Related]
3. US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma.
Kent EE; Breen N; Lewis DR; de Moor JS; Smith AW; Seibel NL
Cancer Causes Control; 2015 Aug; 26(8):1153-62. PubMed ID: 26084209
[TBL] [Abstract][Full Text] [Related]
4. Burden of lymphoma in China, 1990-2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019.
Liu W; Liu J; Song Y; Wang X; Mi L; Cai C; Zhao D; Wang L; Ma J; Zhu J
Aging (Albany NY); 2022 Apr; 14(7):3175-3190. PubMed ID: 35398840
[TBL] [Abstract][Full Text] [Related]
5. Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985.
Robertson CM; Stiller CA; Kingston JE
Arch Dis Child; 1992 Nov; 67(11):1378-83. PubMed ID: 1471892
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
Kahn JM; Keegan TH; Tao L; Abrahão R; Bleyer A; Viny AD
Cancer; 2016 Sep; 122(17):2723-30. PubMed ID: 27286322
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis.
Boyne DJ; Mickle AT; Brenner DR; Friedenreich CM; Cheung WY; Tang KL; Wilson TA; Lorenzetti DL; James MT; Ronksley PE; Rabi DM
Cancer Med; 2018 Sep; 7(9):4801-4813. PubMed ID: 30112841
[TBL] [Abstract][Full Text] [Related]
10. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years.
Linet MS; Brown LM; Mbulaiteye SM; Check D; Ostroumova E; Landgren A; Devesa SS
Int J Cancer; 2016 Apr; 138(8):1862-74. PubMed ID: 26562742
[TBL] [Abstract][Full Text] [Related]
11. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
12. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis.
Huang J; Pang WS; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
J Hematol Oncol; 2022 May; 15(1):57. PubMed ID: 35546241
[TBL] [Abstract][Full Text] [Related]
13. Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990-2019: Results From the Global Burden of Disease Study 2019.
Cai W; Zeng Q; Zhang X; Ruan W
Front Med (Lausanne); 2021; 8():738693. PubMed ID: 34631756
[No Abstract] [Full Text] [Related]
14. Modeling Future Cardiovascular Disease Mortality in the United States: National Trends and Racial and Ethnic Disparities.
Pearson-Stuttard J; Guzman-Castillo M; Penalvo JL; Rehm CD; Afshin A; Danaei G; Kypridemos C; Gaziano T; Mozaffarian D; Capewell S; O'Flaherty M
Circulation; 2016 Mar; 133(10):967-78. PubMed ID: 26846769
[TBL] [Abstract][Full Text] [Related]
15. Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors.
Xiao H; He J; Liang S; Cai D; Zhou Q; Liu L; Yan X; Chi J; Xiao Q; Wang L
Front Oncol; 2021; 11():790891. PubMed ID: 35141149
[TBL] [Abstract][Full Text] [Related]
16. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
[TBL] [Abstract][Full Text] [Related]
18. Mortality Rate of Lymphoma in China, 2013-2020.
Liu W; Qi J; Liu J; Song Y; Wang L; Zhou M; Ma J; Zhu J
Front Oncol; 2022; 12():902643. PubMed ID: 35747821
[TBL] [Abstract][Full Text] [Related]
19. Disparities in Trace Metal Levels in Hodgkin/Non-Hodgkin Lymphoma Patients in Comparison with Controls.
Qayyum MA; Shah MH
Biol Trace Elem Res; 2020 Mar; 194(1):34-47. PubMed ID: 31098833
[TBL] [Abstract][Full Text] [Related]
20. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
